Artificial intelligence and mobile technology combined in a smartphone app demonstrated an ability to accurately measure and respond to urgency of patients' pain.
Pain Management Index scores were found to be inversely associated with the percentage of patients who experience pain interference.
Two single nucleotide polymorphisms in the gene encoding for TAO kinase 3 were found to be associated with higher opioid dose requirements in patients with cancer pain.
The majority of patients with cancer who are being treated with World Health Organization Step III opioids were found to experience poor sleep quality, often due to pain.
In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.
All patients with painful bone metastasis should be referred for palliative radiotherapy to relieve the pain, regardless of age.
Childhood cancer survivors are at risk for long-term peripheral neuropathy, particularly when treated with cisplatin.
Art-based interventions could be easily implemented as an adjunct to conventional therapies for cancer-related pain and mood symptoms.
Researchers conducted a systematic literature review to identify articles that evaluated the efficacy of cryoablation to control cancer pain.
Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility.
Since the legalization of medical marijuana, clinicians must come up with appropriate responses to requests for treatment in pediatric end-of-life settings.
Nitrous Oxide/Oxygen Mixture as Adjunct to Morphine May Provide Relief From Breakthrough Cancer PainJanuary 22, 2018
Self-administration of a nitrous oxide/oxygen mixture may be more effective than oxygen alone as an adjunct analgesic treatment in reducing moderate to severe breakthrough cancer pain.
Although much of the response to the opioid epidemic exempts treatment for cancer-related pain, a recent Oncology Nurse Advisor online survey showed that more than 80% of respondents were concerned about how current restrictions set up to manage the opioid crisis are affecting cancer patient pain management.
Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy.
The FDA recommended the approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL).
WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.
Pain is far more common and widespread in ALS than previously suspected, and initial pain symptoms may predate the clinical onset of the disease's hallmark motor dysfunction by as much as 2 years.
A guideline update from the American Society for Radiation Oncology continues to support the efficacy and safety of palliative radiation therapy for bone metastases.
Fentanyl sublingual tablets are preferred over subcutaneous morphine in patients with severe breakthrough cancer pain.
Although opioids are considered a first-line treatment for late-stage cancer pain, they are often prescribed relatively late and for only a short duration before death in many patients.
Depomed has announced that Lazanda (fentanyl) nasal spray, CII, is now available at 300mcg dose strength to treat cancer pain.
Intrathecal therapy represents a valuable option for many patients with severe, refractory chronic pain.
In states where marijuana is legalized for medicinal purposes, Medicare's prescription drug benefit program has lowered its spending due to reduced prescription drug use.
The American Pain Society next month will be welcoming pain researchers to its 35th Annual Scientific Meeting. Attendees can expect an array of educational sessions focusing on acute pain, chronic cancer and noncancer pain, and recurrent pain.
Are we overestimating the efficacy of step III analgesics?
Patients who listened to guided meditation or music during their biopsy reported significantly greater reductions in anxiety and fatigue than standard care.
Calmare therapy may be an effective option for treating cancer-related neuropathic pain.
Earlier hospice enrollment important area to focus on to improve the quality of end-of-life cancer care.
Greater cost savings for cancer patients with more comorbidities.
Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis.
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Opioids: Clinician Concern and Prescribing Practices
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Ensuring Safety During Long-Term Opioid Therapy
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
- Patient Experiences Shed Light on Diagnostic Errors
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Wikipedia in Medical Education: An Educator's Guide to Crowdsourcing